The October issue of Medical Express

Abstract

MedicalExpress is happy to announce the coming of its 5 th issue, October 2014. This is where we move ahead towards accomplishing one more of our goals, which is to publish in continuous flow: following this editorial you have the first three original research articles of volume 1(5). Others will follow, as their processing becomes complete. The most significant piece of news at the time of writing is that MedicalExpress has now acquired the necessary credentials and has formally applied for indexation in SciELO, the Brazilian based Scientific Electronic Library Online. We expect to have news on this development before the end of this year. Our previous, 4 th issue, dated August 2014, came out en bloc in July 11th. The 11 titles therein (8 original research articles, 3 reviews) were processed as shown in Table 1. We are moving towards our average goal of 10 articles per issue; our initial response time has remained quite steady whereas our interval between acceptance and publication has fallen to 44 days in the fourth issue. We expect to publish 11 articles in October totalizing 48 in the first five issues (9.6 articles per issue). The table does not show time from submission to publication, because this statistic includes time controlled by authors, not by the journal. The August issue was the largest, so far, with three reviews, seven original research papers and one rapid communication. Oliveira et al reviewed present state of the art technology for cerebrospinal shunt circuitry with emphasis on the development of last generation valves. Iuamoto et al reviewed available reports on the viability of islet allotransplantation in rats and the amelioration of survival with the use of the latest immunosuppressive agents. Campos reviews recent recommendations concerning the use of Chondroprotective agents in osteoarthritic patients and makes a strong case for their use despite negative recommendations by learned international rheumatologic institutions Gotfryd et al retrospectively evaluated back * original research, rapid communication and reviews.